A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo Aspiration System

NCT ID: NCT04144959

Last Updated: 2025-06-27

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

119 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-12-17

Study Completion Date

2023-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this study is to collect safety and performance data on the Indigo Aspiration System in a patient population with lower extremity acute limb ischemia (LE ALI).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lower Extremity Acute Limb Ischemia LE ALI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with lower extremity acute limb ischemia

Indigo Aspiration System

Intervention Type DEVICE

Indigo Aspiration System

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Indigo Aspiration System

Indigo Aspiration System

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient age ≥ 18
* Patient presents with acute (≤14 days) occlusion of lower limb artery(ies) (below inguinal ligament)
* Patient with a Rutherford Category I, IIa or IIb score
* Frontline treatment with Indigo Aspiration System
* Informed consent is obtained from either patient or legally authorized representative (LAR)

Exclusion Criteria

* Life expectancy \<1 year
* Vessel size \<2 mm
* LE ALI secondary to dissections, vasculitis, and/or target vessel trauma
* Amputation in the ipsilateral limb
* Pregnancy or positive pregnancy test according to site specific standards of care (only required for women of child bearing potential, serum or urine acceptable)
* Absolute contraindication to contrast administration
* Patient is unwilling or unable to comply with protocol follow up schedule and/or based on the Investigator's judgment the patient is not a good study candidate
* Currently participating in an investigational drug or device clinical trial that may confound the study endpoints. Patients in observational, natural history, and/or epidemiological studies not involving intervention are eligible.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Penumbra Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas Maldonado, MD

Role: PRINCIPAL_INVESTIGATOR

NYU Langone Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University Medical Center

Stanford, California, United States

Site Status

Danbury Hospital

Danbury, Connecticut, United States

Site Status

Manatee Memorial Hospital

Bradenton, Florida, United States

Site Status

Baptist Hospital of Miami

Miami, Florida, United States

Site Status

University of Maryland

Baltimore, Maryland, United States

Site Status

Albany Medical Center

Albany, New York, United States

Site Status

Tisch Hospital NYU Langone Health

New York, New York, United States

Site Status

NC Heart and Vascular Research

Cary, North Carolina, United States

Site Status

Sanger Heart & Vascular Institute

Charlotte, North Carolina, United States

Site Status

Trihealth Good Samaritan Hospital of Cincinnati

Cincinnati, Ohio, United States

Site Status

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

Holston Valley Medical

Kingsport, Tennessee, United States

Site Status

Baylor College of Medicine (St. Luke's Medical Center)

Houston, Texas, United States

Site Status

Sentara Vascular Specialists

Norfolk, Virginia, United States

Site Status

Klinikum rechts der Isar

München, , Germany

Site Status

St. Franziskus-Hospital - Münster

Münster, , Germany

Site Status

Hospital Clínico Universitario de Santiago

Santiago de Compostela, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Germany Spain

References

Explore related publications, articles, or registry entries linked to this study.

Maldonado TS, Powell A, Wendorff H, Rowse J, Nagarsheth KH, Dexter DJ, Dietzek AM, Muck PE, Arko FR, Chung J; STRIDE study group. Safety and efficacy of mechanical aspiration thrombectomy for patients with acute lower extremity ischemia. J Vasc Surg. 2024 Mar;79(3):584-592.e5. doi: 10.1016/j.jvs.2023.10.062. Epub 2023 Nov 4.

Reference Type DERIVED
PMID: 37931885 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLP 15549

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The ArtixASCEND Study
NCT07135895 NOT_YET_RECRUITING NA